株探米国株
日本語 英語
エドガーで原本を確認する
0001670541FALSE00016705412023-11-082023-11-08

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934

Date of Report (date of earliest event reported): November 8, 2023

ADIENT PLC
(Exact name of registrant as specified in its charter)

Ireland 001-37757 98-1328821
(State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification Number)
 3 Dublin Landings, North Wall Quay
Dublin 1, Ireland D01 H104
(Address of principal executive offices)

Registrant’s telephone number, including area code: 734-254-5000

Not applicable
(Former name or former address, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:
Title of class Trading symbol(s) Name of exchange on which registered
Ordinary Shares, par value $0.001 ADNT New York Stock Exchange


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrants under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17     CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))



Indicate by check mark whether the Registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



Item 2.02 Results of Operations and Financial Condition.

On November 8, 2023, Adient plc (the “Company”) issued a news release announcing its financial results for the fourth quarter and fiscal year ended September 30, 2023. The news release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The information contained in Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.


Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.
EXHIBIT INDEX
Exhibit No. Exhibit Description
99.1
104
Cover Page Interactive Data File (the Cover Page Interactive Data File is embedded within the Inline XBRL document).


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

ADIENT PLC
Date: November 8, 2023 By: /s/ Heather M. Tiltmann
Name: Heather M. Tiltmann
Title:
Executive Vice President, Chief Legal and Human Resources Officer, and Corporate Secretary


EX-99.1 2 a110823adientexhibit991.htm EX-99.1 Document
Exhibit 99.1
q4fy23-earningsinfographicd.jpg


q4fy23-earningsinfographice.jpg



q4fy23-earningsinfographicf.jpg


q4fy23-earningsinfographicg.jpg

Appendix
Page 1

Adient plc
Condensed Consolidated Statements of Income
(Unaudited)
Three Months Ended
September 30,		 Twelve Months Ended
September 30,
(in millions, except per share data) 2023 2022 2023 2022
Net sales $ 3,729  $ 3,650  $ 15,395  $ 14,121 
Cost of sales 3,479  3,367  14,362  13,314 
Gross profit 250  283  1,033  807 
Selling, general and administrative expenses 127  159  554  598 
Restructuring and impairment costs 10  5  40  25 
Equity income (loss) 27  19  84  75 
Earnings (loss) before interest and income taxes 140  138  523  259 
Net financing charges 46  43  195  215 
Other pension expense (income) 21  (4) 33  (10)
Income (loss) before income taxes 73  99  295  54 
Income tax provision (benefit) (84) 29  —  94 
Net income (loss) 157  70  295  (40)
Income attributable to noncontrolling interests 22  25  90  80 
Net income (loss) attributable to Adient $ 135  $ 45  $ 205  $ (120)
Diluted earnings (loss) per share $ 1.42  $ 0.47  $ 2.15  $ (1.27)
Shares outstanding at period end 93.7  94.9  93.7  94.9 
Diluted weighted average shares 94.8  96.0  95.4  94.8 




Appendix
Page 2

Adient plc
Condensed Consolidated Statements of Financial Position
(Unaudited)

September 30,
(in millions) 2023 2022
Assets
Cash and cash equivalents $ 1,110  $ 947 
Accounts receivable - net
 1,874  1,852 
Inventories 841  953 
Other current assets 491  411 
Current assets 4,316  4,163 
Property, plant and equipment - net 1,382  1,377 
Goodwill 2,094  2,057 
Other intangible assets - net 408  467 
Investments in partially-owned affiliates 303  286 
Assets held for sale 7  11 
Other noncurrent assets 914  797 
Total assets $ 9,424  $ 9,158 
Liabilities and Shareholders' Equity
Short-term debt $ 134  $ 14 
Accounts payable and accrued expenses 2,926  2,818 
Other current liabilities 678  669 
Current liabilities 3,738  3,501 
Long-term debt 2,401  2,564 
Other noncurrent liabilities 682  673 
Redeemable noncontrolling interests 57  45 
Shareholders' equity attributable to Adient 2,228  2,073 
Noncontrolling interests 318  302 
Total liabilities and shareholders' equity $ 9,424  $ 9,158 



Appendix
Page 3

Adient plc
Condensed Consolidated Statements of Cash Flows
(Unaudited)

Three Months Ended
September 30,		 Twelve Months Ended
September 30,
(in millions) 2023 2022 2023 2022
Operating Activities
Net income (loss) attributable to Adient $ 135  $ 45  $ 205  $ (120)
Income attributable to noncontrolling interests 22  25  90  80 
Net income (loss) 157  70  295  (40)
Adjustments to reconcile net income (loss) to cash provided (used) by operating activities:
Depreciation 76  75  290  298 
Amortization of intangibles 12  12  50  52 
Pension and postretirement benefit expense (benefit) 22  (1) 38  (2)
Pension and postretirement contributions, net (6) 1  (17) (16)
Equity in earnings of partially-owned affiliates, net of dividends received (7) 42  (34) 4 
(Gain) on sale / impairment of nonconsolidated partially owned affiliate —  2  6  10 
Premium paid on repurchase of debt —  4  7  38 
Retrospective recoveries of Brazil indirect tax credits —  (29) —  (29)
Derivative loss on China Transactions —  —  —  3 
Deferred income taxes (122) —  (124) 5 
Non-cash restructuring and impairment charges —  2  —  14 
Equity-based compensation 9  8  34  29 
Other (7) 3  (4) 17 
Changes in assets and liabilities:
Receivables 186  (161) 16  (576)
Inventories 6  (36) 126  (62)
Other assets 58  (30) (26) 32 
Restructuring reserves (8) (8) (53) (57)
Accounts payable and accrued liabilities (99) 259  34  542 
Accrued income taxes 17  23  29  12 
Cash provided (used) by operating activities 294  236  667  274 
Investing Activities
Capital expenditures (75) (57) (252) (227)
Sale of property, plant and equipment 10  2  26  20 
Settlement of derivatives —  —  —  (30)
Acquisition of businesses, net of cash acquired —  —  (6) (19)
Business divestitures —  —  5  740 
Other —  —  (2) — 
Cash provided (used) by investing activities (65) (55) (229) 484 
Financing Activities
Increase (decrease) in short-term debt 1  (6) (1) (14)
Increase (decrease) in long-term debt —  —  1,002  — 
Repayment of long-term debt —  (99) (1,104) (987)
Debt financing costs —  —  (23) (1)
Share repurchases —  —  (65) — 
Cash paid to acquire a noncontrolling interest —  —  —  (153)
Dividends paid to noncontrolling interests (10) (4) (67) (106)
Other (1) —  (13) (12)
Cash provided (used) by financing activities (10) (109) (271) (1,273)
Effect of exchange rate changes on cash and cash equivalents (17) (17) (4) (59)
Increase (decrease) in cash and cash equivalents $ 202  $ 55  $ 163  $ (574)


Appendix
Page 4

Footnotes
1. Segment Results

Adient manages its business on a geographic basis and operates in the following three reportable segments for financial reporting purposes: 1) Americas, which is inclusive of North America and South America; 2) Europe, Middle East, and Africa ("EMEA") and 3) Asia Pacific/China ("Asia").

Adient evaluates the performance of its reportable segments using an adjusted EBITDA metric defined as income before income taxes and noncontrolling interests, excluding net financing charges, qualified restructuring and impairment costs, restructuring related-costs, net mark-to-market adjustments on pension and postretirement plans, transaction gains/losses, purchase accounting amortization, depreciation, stock-based compensation and other non-recurring items ("Adjusted EBITDA"). Also, certain corporate-related costs are not allocated to the segments. The reportable segments are consistent with how management views the markets served by Adient and reflect the financial information that is reviewed by its chief operating decision maker.

Financial information relating to Adient's reportable segments is as follows:

Three Months Ended September 30, Twelve Months Ended September 30,
(in millions) 2023 2022 2023 2022
Net Sales
Americas $ 1,835  $ 1,790  $ 7,220  $ 6,557 
EMEA 1,174  1,101  5,195  4,764 
Asia 748  792  3,085  2,926 
Eliminations (28) (33) (105) (126)
Total net sales $ 3,729  $ 3,650  $ 15,395  $ 14,121 

Three Months Ended
September 30,		 Twelve Months Ended
September 30,
(in millions) 2023 2022 2023 2022
Adjusted EBITDA
Americas $ 100  $ 117  $ 336  $ 242 
EMEA 48  34  232  138 
Asia 113  100  464  383 
Corporate-related costs (1)
 (26) (24) (94) (88)
Restructuring and impairment costs (2)
 (10) (5) (40) (25)
Purchase accounting amortization (3)
 (13) (13) (52) (54)
Restructuring related activities (4)
 8  (1) 2  (6)
Stock based compensation (9) (8) (34) (29)
Depreciation (76) (75) (290) (298)
Other items (5)
 5  13  (1) (4)
Earnings (loss) before interest and income taxes 140  138  523  259 
Net financing charges (46) (43) (195) (215)
Other pension income (expense) (21) 4  (33) 10 
Income (loss) before income taxes $ 73  $ 99  $ 295  $ 54 

Refer to the Footnote Addendum for footnote explanations.


Appendix
Page 5


2. Earnings Per Share

The following table reconciles the numerators and denominators used to calculate basic and diluted earnings (loss) per share:

Three Months Ended
September 30,		 Twelve Months Ended
September 30,
(in millions, except per share data) 2023 2022 2023 2022
Income available to shareholders
Net income (loss) attributable to Adient $ 135  $ 45  $ 205  $ (120)
Weighted average shares outstanding
Basic weighted average shares outstanding 93.7  94.8  94.5  94.8 
Effect of dilutive securities:
Stock options, unvested restricted stock and unvested performance share awards 1.1  1.2  0.9  — 
Diluted weighted average shares outstanding 94.8  96.0  95.4  94.8 

Potentially dilutive securities whose effect would have been antidilutive are excluded from the computation of diluted earnings per share, which for the twelve months ended September 30, 2022 is a result of being in a loss position.


Appendix
Page 6

3. Non-GAAP Measures

Adjusted EBIT, Adjusted EBIT margin, Adjusted EBITDA, Adjusted EBITDA margin, Adjusted net income attributable to Adient, Adjusted effective tax rate, Adjusted earnings per share, Adjusted equity income, Adjusted interest expense, Free cash flow, Net debt, and Net leverage ratio as well as other measures presented on an adjusted basis are not recognized terms under U.S. GAAP and do not purport to be alternatives to the most comparable U.S. GAAP amounts. Since all companies do not use identical calculations, our definition and presentation of these measures may not be comparable to similarly titled measures reported by other companies. Management uses the identified non-GAAP measures to evaluate the operating performance of the Company and its business segments and to forecast future periods. Management believes these non-GAAP measures assist investors and other interested parties in evaluating Adient's on-going operations and provide important supplemental information to management and investors regarding financial and business trends relating to Adient's financial condition and results of operations. Investors should not consider these non-GAAP measures as alternatives to the related GAAP measures. Reconciliations of non-GAAP measures to their closest U.S. GAAP equivalent are presented below. Reconciliations of non-GAAP measures related to guidance for any future period have not been provided due to the unreasonable efforts it would take to provide such reconciliations.

• Adjusted EBIT is defined as income before income taxes and noncontrolling interests excluding net financing charges, restructuring, impairment and related costs, purchase accounting amortization, transaction gains/losses, other significant non-recurring items, and net mark-to-market adjustments on pension and postretirement plans. Adjusted EBIT margin is adjusted EBIT as a percentage of net sales.
• Adjusted EBITDA is defined as adjusted EBIT excluding depreciation and stock based compensation. Certain corporate-related costs are not allocated to the business segments in determining Adjusted EBITDA. Adjusted EBITDA margin is adjusted EBITDA as a percentage of net sales. Adjusted EBITDA excluding adjusted equity income, each as defined herein, is also presented.
• Adjusted net income attributable to Adient is defined as net income attributable to Adient excluding restructuring, impairment and related costs, purchase accounting amortization, transaction gains/losses, expenses associated with becoming an independent company, other significant non-recurring items, net mark-to-market adjustments on pension and postretirement plans, the tax impact of these items and other discrete tax charges/benefits.
• Adjusted effective tax rate is defined as adjusted income tax provision as a percentage of adjusted income before income taxes.
• Adjusted earnings per share is defined as Adjusted net income attributable to Adient divided by diluted weighted average shares.
• Adjusted equity income is defined as equity income excluding amortization of Adient's intangible assets related to its non-consolidated joint ventures and other unusual or one-time items impacting equity income.
• Adjusted interest expense is defined as net financing charges excluding unusual or one-time items impacting interest expense.
• Free cash flow is defined as cash provided by operating activities less capital expenditures.
• Net debt is calculated as gross debt (short-term and long-term) less cash and cash equivalents.
• Net leverage ratio is calculated as net debt divided by LTM Adjusted EBITDA



Appendix
Page 7

Summarized Income Statement Information
(Refer to the Footnote Addendum for footnote explanations and details
of reconciling items between GAAP results and Adjusted results)

Three Months Ended September 30,
2023 2022
(in millions, except per share data) GAAP Results Adj. Adjusted Results GAAP Results Adj. Adjusted Results
Net sales $ 3,729  $ —  $ 3,729  $ 3,650  $ —  $ 3,650 
Cost of sales (6)
 3,479  —  3,479  3,367  29  3,396 
Gross profit 250  —  250  283  (29) 254 
Selling, general and administrative expenses (7)
 127  (3) 124  159  (28) 131 
Restructuring and impairment costs (2)
 10  (10) —  5  (5) — 
Equity income (loss) (8)
 27  (3) 24  19  2  21 
Earnings (loss) before interest and income taxes (EBIT) 140  10  150  138  6  144 
Memo accounts:
Depreciation 76  75 
Equity based compensation costs 9  8 
Adjusted EBITDA $ 235  $ 227 
Net financing charges (9)
 46  —  46  43  (5) 38 
Other pension expense (income) (10)
 21  (19) 2  (4) 3  (1)
Income (loss) before income taxes 73  29  102  99  8  107 
Income tax provision (benefit) (11)
 (84) 115  31  29  —  29 
Net income (loss) attributable to Adient 135  (87) 48  45  6  51 
Diluted earnings (loss) per share 1.42  (0.91) 0.51  0.47  0.06  0.53 
Diluted weighted average shares 94.8  —  94.8  96.0  —  96.0 





















Appendix
Page 8

Summarized Income Statement Information
(Refer to the Footnote Addendum for footnote explanations and details
of reconciling items between GAAP results and Adjusted results)

Twelve Months Ended September 30,
2023 2022
(in millions, except per share data) GAAP Results Adj. Adjusted Results GAAP Results Adj. Adjusted Results
Net sales $ 15,395  $ —  $ 15,395  $ 14,121  $ —  $ 14,121 
Cost of sales (6)
 14,362  (2) 14,360  13,314  26  13,340 
Gross profit 1,033  2  1,035  807  (26) 781 
Selling, general and administrative expenses (7)
 554  (43) 511  598  (77) 521 
Restructuring and impairment costs (2)
 40  (40) —  25  (25) — 
Equity income (loss) (8)
 84  6  90  75  13  88 
Earnings (loss) before interest and income taxes (EBIT) 523  91  614  259  89  348 
Memo accounts:
Depreciation 290  298 
Equity based compensation costs 34  29 
Adjusted EBITDA $ 938  $ 675 
Net financing charges (9)
 195  (11) 184  215  (52) 163 
Other pension expense (income) (10)
 33  (27) 6  (10) 6  (4)
Income (loss) before income taxes 295  129  424  54  135  189 
Income tax provision (benefit) (11)
 —  123  123  94  (3) 91 
Net income (loss) attributable to Adient 205  —  205  (120) 131  11 
Diluted earnings (loss) per share 2.15  —  2.15  (1.27) 1.38  0.11 
Diluted weighted average shares 95.4  —  95.4  94.8  1.0  95.8 





















Appendix
Page 9

Segment Performance:
Three months ended September 30, 2023
Americas EMEA Asia Corporate/Eliminations Consolidated
Net sales $ 1,835  $ 1,174  $ 748  $ (28) $ 3,729 
Adjusted EBITDA $ 100  $ 48  $ 113  $ (26) $ 235 
Adjusted EBITDA margin 5.4  % 4.1  % 15.1  % N/A 6.3  %
Three months ended September 30, 2022
Americas EMEA Asia Corporate/Eliminations Consolidated
Net sales $ 1,790  $ 1,101  $ 792  $ (33) $ 3,650 
Adjusted EBITDA $ 117  $ 34  $ 100  $ (24) $ 227 
Adjusted EBITDA margin 6.5  % 3.1  % 12.6  % N/A 6.2  %
Twelve months ended September 30, 2023
Americas EMEA Asia Corporate/Eliminations Consolidated
Net sales $ 7,220  $ 5,195  $ 3,085  $ (105) $ 15,395 
Adjusted EBITDA $ 336  $ 232  $ 464  $ (94) $ 938 
Adjusted EBITDA margin 4.7  % 4.5  % 15.0  % N/A 6.1  %
Twelve months ended September 30, 2022
Americas EMEA Asia Corporate/Eliminations Consolidated
Net sales $ 6,557  $ 4,764  $ 2,926  $ (126) $ 14,121 
Adjusted EBITDA $ 242  $ 138  $ 383  $ (88) $ 675 
Adjusted EBITDA margin 3.7  % 2.9  % 13.1  % N/A 4.8  %


The following table presents adjusted EBITDA excluding adjusted equity income:

Three Months Ended
September 30,		 Twelve Months Ended September 30,
(in millions) 2023 2022 2023 2022
Adjusted EBITDA $ 235  $ 227  $ 938  $ 675 
Less: Adjusted equity income 24  21  90  88 
Adjusted EBITDA excluding adjusted equity income $ 211  $ 206  $ 848  $ 587 
% of Sales 5.8  % 5.6  % 6.0  % 4.2  %


Appendix
Page 10

The following table reconciles income (loss) before income taxes to adjusted income before income taxes and presents the related effective tax rate and adjusted effective tax rate:

Three Months Ended September 30,
2023 2022
(in millions, except effective tax rate) Income (loss) before income taxes Tax impact Effective tax rate Income (loss) before income taxes Tax impact Effective tax rate
As reported $ 73  $ (84) * nm $ 99  $ 29  29.3%
Adjustments (11)
 29  115  * nm 8  —  —%
As adjusted $ 102  $ 31  30.4% $ 107  $ 29  27.1%

Twelve Months Ended September 30,
2023 2022
(in millions, except effective tax rate) Income (loss) before income taxes Tax impact Effective tax rate Income (loss) before income taxes Tax impact Effective tax rate
As reported 295  $ —  —% $ 54  $ 94  * nm
Adjustments (11)
 129  123  95.3% 135  (3) (2.2)%
As adjusted $ 424  $ 123  29.0% $ 189  $ 91  48.1%

* Measure not meaningful.


The following table reconciles net income (loss) attributable to Adient to adjusted net income (loss) attributable to Adient:

Three Months Ended
September 30,		 Twelve Months Ended
September 30,
(in millions) 2023 2022 2023 2022
Net income (loss) attributable to Adient $ 135  $ 45  $ 205  $ (120)
Restructuring and impairment costs (2)
 10  5  40  25 
Purchase accounting amortization (3)
 13  13  52  54 
Restructuring related activities (4)
 (8) 1  (2) 6 
Pension mark-to-market and settlement (gain) loss (10)
 19  (3) 27  (6)
Write off of deferred financing charges upon repurchase of debt (9)
 —  1  4  8 
Derivative loss on China transactions (9)
 —  —  —  3 
Foreign exchange loss on intercompany loan in Russia (9)
 —  —  —  3 
Premium paid on repurchase of debt (9)
 —  4  7  38 
Other items (5)
 (5) (13) 1  4 
Impact of adjustments on noncontrolling interests (12)
 (1) (2) (6) (7)
Tax impact of above adjustments and other tax items (11)
 (115) —  (123) 3 
Adjusted net income (loss) attributable to Adient $ 48  $ 51  $ 205  $ 11 

Refer to the Footnote Addendum for footnote explanations

Appendix
Page 11

The following table reconciles diluted earnings (loss) per share as reported to adjusted diluted earnings per share:

Three Months Ended
September 30,		 Twelve Months Ended
September 30,
2023 2022 2023 2022
Diluted earnings (loss) per share as reported $ 1.42  $ 0.47  $ 2.15  $ (1.27)
Restructuring and impairment costs (2)
 0.11  0.05  0.42  0.26 
Purchase accounting amortization (3)
 0.14  0.14  0.55  0.58 
Restructuring related activities (4)
 (0.08) 0.01  (0.02) 0.06 
Pension mark-to-market and settlement gain/loss (10)
 0.20  (0.03) 0.28  (0.06)
Write off of deferred financing charges upon repurchase of debt (9)
 —  0.01  0.04  0.08 
Derivative loss on China transactions (9)
 —  —  —  0.03 
Foreign exchange (gain) loss on intercompany loan in Russia (9)
 —  —  —  0.03 
Premium paid on repurchase of debt (9)
 —  0.04  0.07  0.40 
Other items (5)
 (0.05) (0.14) 0.01  0.04 
Impact of adjustments on noncontrolling interests (12)
 (0.01) (0.02) (0.06) (0.07)
Tax impact of above adjustments and other tax items (11)
 (1.22) —  (1.29) 0.03 
Adjusted diluted earnings (loss) per share $ 0.51  $ 0.53  $ 2.15  $ 0.11 


The following table presents calculations of net debt and net leverage ratio:


September 30,
(in millions) 2023 2022
Cash $ 1,110  $ 947 
Total debt 2,535  2,578 
Net debt $ 1,425  $ 1,631 
LTM Adjusted EBITDA $ 938  $ 675 
Net leverage ratio 1.52 2.42

The following table reconciles cash from operating activities to free cash flow:

Three Months Ended
September 30,		 Twelve Months Ended
September 30,
(in millions) 2023 2022 2023 2022
Operating cash flow $ 294  $ 236  $ 667  $ 274 
Capital expenditures (75) (57) (252) (227)
Free cash flow $ 219  $ 179  $ 415  $ 47 



Appendix
Page 12

The following table reconciles adjusted EBITDA to Free cash flow:

FY23 FY22
(in millions) Q4 YTD Q4 YTD
Adjusted EBITDA excluding adjusted equity income $ 211  $ 848  $ 206  $ 587 
Dividends received from nonconsolidated partially-owned affiliates
 20  56  62  89 
Restructuring (cash) (11) (60) (9) (57)
Net Customer Tooling (7) (47) 32  (4)
Trade Working Capital (Net AR/AP + Inventory) 58  37  (15) (21)
Accrued Compensation 16  57  2  (43)
Interest paid (38) (145) (58) (192)
Tax refund/taxes paid (20) (94) (14) (77)
Non-income related taxes (VAT) 9  4  —  33 
Commercial settlements 51  87  31  (35)
Capitalized engineering (8) (33) (4) 29 
Prepaids 32  (9) 22  15 
Other (19) (34) (19) (50)
Operating cash flow 294  667  236  274 
Capital expenditures (75) (252) (57) (227)
Free cash flow $ 219  $ 415  $ 179  $ 47 




Appendix
Page 13


Footnote Addendum

(1) Corporate-related costs not allocated to the segments include executive office, communications, corporate development, legal and corporate finance.

(2) Reflects qualified restructuring charges for costs that are directly attributable to restructuring activities and meet the definition of restructuring under ASC 420 and one-time asset impairments, as follows:

Three Months Ended
September 30,		 Twelve Months Ended
September 30,
(in millions) 2023 2022 2023 2022
Restructuring charges $ (10) $ (3) $ (40) $ (15)
Held for sale and other asset adjustments —  —  —  (6)
Impairment charge associated with Russian operations —  (2) —  (4)
$ (10) $ (5) $ (40) $ (25)

(3) Reflects amortization of intangible assets including those related to partially owned affiliates recorded within equity income.

(4) Reflects non-qualified restructuring charges for costs that are directly attributable to restructuring activities, but do not meet the definition of restructuring under ASC 420 along with a gain on sale of a restructured facility in the America's segment for three and twelve month ended September 30, 2023, as follows:

Three Months Ended
September 30,		 Twelve Months Ended
September 30,
(in millions) 2023 2022 2023 2022
Restructuring related charges $ (2) $ (1) $ (8) $ (6)
Gain on sale of restructured facility 10  —  10  — 
$ 8  $ (1) $ 2  $ (6)

(5) Other items include:

Three Months Ended
September 30,		 Twelve Months Ended
September 30,
(in millions) 2023 2022 2023 2022
Transaction costs $ —  $ (1) $ (3) $ (8)
Brazil indirect tax recoveries 1  29  4  32 
Non-recurring contract related settlement —  (14) —  (14)
One-time divestiture gain at an affiliate 4  —  4  — 
Loss on sale / impairment of nonconsolidated partially-owned affiliates
 —  (1) (6) (10)
Other —  —  —  (4)
$ 5  $ 13  $ (1) $ (4)




Appendix
Page 14


(6) The adjustments to cost of sales include:

Three Months Ended
September 30,		 Twelve Months Ended
September 30,
(in millions) 2023 2022 2023 2022
Purchase accounting amortization $ —  $ —  $ (1) $ (1)
Restructuring related charges (1) —  (5) (4)
Brazil indirect tax recoveries 1  29  4  32 
Other —  —  —  (1)
$ —  $ 29  $ (2) $ 26 

(7) The adjustments to selling, general and administrative costs include:

Three Months Ended
September 30,		 Twelve Months Ended
September 30,
(in millions) 2023 2022 2023 2022
Purchase accounting amortization $ (12) $ (12) $ (49) $ (51)
Gain on sale of restructured facility 10  —  10  — 
Restructuring related charges (1) (1) (1) (1)
Transaction costs —  (1) (3) (8)
Non-recurring contract related settlement —  (14) —  (14)
Other —  —  —  (3)
$ (3) $ (28) $ (43) $ (77)

(8) The adjustments to equity income include:

Three Months Ended
September 30,		 Twelve Months Ended
September 30,
(in millions) 2023 2022 2023 2022
Purchase accounting amortization
 $ 1  $ 1  $ 2  $ 2 
Gain on sale of certain assets at affiliates in China (4) (7) (4) (7)
Restructuring related charges
 —  —  2  1 
(Gain) loss on sale / impairment of nonconsolidated partially-owned affiliates
 —  1  6  10 
Customer termination charge —  7  —  7 
$ (3) $ 2  $ 6  $ 13 

(9) The adjustments to net financing charges include:

Three Months Ended
September 30,		 Twelve Months Ended
September 30,
(in millions) 2023 2022 2023 2022
Premium paid on repurchase of debt $ —  $ (4) $ (7) $ (38)
Write off of deferred financing charges upon repurchase of debt —  (1) (4) (8)
Derivative loss on China transactions —  —  —  (3)
Foreign exchange loss on intercompany loan in Russia —  —  —  (3)
$ —  $ (5) $ (11) $ (52)


Appendix
Page 15

(10) The adjustments to other pension expense (income) include:

Three Months Ended
September 30,		 Twelve Months Ended
September 30,
(in millions) 2023 2022 2023 2022
Mark-to-market adjustment gain (loss) $ (19) $ 3  $ (19) $ 7 
One-time settlement and curtailment gain (loss) —  —  (8) (1)
$ (19) $ 3  $ (27) $ 6 

(11) The adjustments to income tax provision (benefit) include:

Three Months Ended
September 30,		 Twelve Months Ended
September 30,
(in millions) 2023 2022 2023 2022
Tax rate change $ —  $ —  $ —  $ 4 
Brazil indirect tax recoveries —  (7) —  (4)
Valuation allowances 112  8  111  (4)
Amortization 1  1  6  7 
Pension mark-to-market and settlement loss 1  —  3  — 
Other reconciling items 1  (2) 3  (6)
$ 115  $ —  $ 123  $ (3)

(12) Reflects the impacts of adjustments, primarily purchase accounting amortization and changes in income tax rates, on noncontrolling interests.